Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases

Detalhes bibliográficos
Autor(a) principal: Martins, Sarah Moherdaui
Data de Publicação: 2018
Outros Autores: Müller, Vinicius, Galan, Vanderson, Souza, Fabio Pinheiro de, Andreazza, Itamar Francisco, Rosa, Maurício Ferreira da
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
Texto Completo: https://www.revistas.usp.br/bjps/article/view/159105
Resumo: Multiparticulate systems have biopharmaceutical advantages when compared to the monolithic systems, once they allow different patterns of drug release and can be used in different treatments. The aim of the present work was to develop a biphasic controlled release delivery system, using propranolol hydrochloride (PROP) that can be used for the treatment of circadian diseases. This system was obtained by the combination of cellulosic polymers hydroxypropyl methylcellulose (HPMC) and ethylcellulose (EC) in a 2² factorial experimental design, which allowed the optimization of the development stage. The pellets produced and used in biphasic formulations were evaluated for physical and chemical characteristics and presented acceptable results. The immediate fraction obtained showed the complete release in 30 min while the others kept the release of the drug for 24 h. This study showed that the combination of beads with different releasing characteristics allowed to obtain different release profiles, which can be modulated according to the pathological needs, especially with regard to circadian diseases that suffer alterations throughout the day.
id USP-31_7857c5897454540a850bf8f025c8f9d4
oai_identifier_str oai:revistas.usp.br:article/159105
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
repository_id_str
spelling Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseasesChronotherapyBiphasic ReleasePelletsCellulosic PolymersExperimental DesignMultiparticulate systems have biopharmaceutical advantages when compared to the monolithic systems, once they allow different patterns of drug release and can be used in different treatments. The aim of the present work was to develop a biphasic controlled release delivery system, using propranolol hydrochloride (PROP) that can be used for the treatment of circadian diseases. This system was obtained by the combination of cellulosic polymers hydroxypropyl methylcellulose (HPMC) and ethylcellulose (EC) in a 2² factorial experimental design, which allowed the optimization of the development stage. The pellets produced and used in biphasic formulations were evaluated for physical and chemical characteristics and presented acceptable results. The immediate fraction obtained showed the complete release in 30 min while the others kept the release of the drug for 24 h. This study showed that the combination of beads with different releasing characteristics allowed to obtain different release profiles, which can be modulated according to the pathological needs, especially with regard to circadian diseases that suffer alterations throughout the day.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2018-12-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/15910510.1590/s2175-97902018000417167Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17167Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17167Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e171672175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/159105/154015Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciencesinfo:eu-repo/semantics/openAccessMartins, Sarah MoherdauiMüller, ViniciusGalan, VandersonSouza, Fabio Pinheiro deAndreazza, Itamar FranciscoRosa, Maurício Ferreira da2019-06-24T20:15:38Zoai:revistas.usp.br:article/159105Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2019-06-24T20:15:38Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
title Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
spellingShingle Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
Martins, Sarah Moherdaui
Chronotherapy
Biphasic Release
Pellets
Cellulosic Polymers
Experimental Design
title_short Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
title_full Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
title_fullStr Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
title_full_unstemmed Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
title_sort Development and evaluation of multiparticulate biphasic system for the treatment of circadian diseases
author Martins, Sarah Moherdaui
author_facet Martins, Sarah Moherdaui
Müller, Vinicius
Galan, Vanderson
Souza, Fabio Pinheiro de
Andreazza, Itamar Francisco
Rosa, Maurício Ferreira da
author_role author
author2 Müller, Vinicius
Galan, Vanderson
Souza, Fabio Pinheiro de
Andreazza, Itamar Francisco
Rosa, Maurício Ferreira da
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Martins, Sarah Moherdaui
Müller, Vinicius
Galan, Vanderson
Souza, Fabio Pinheiro de
Andreazza, Itamar Francisco
Rosa, Maurício Ferreira da
dc.subject.por.fl_str_mv Chronotherapy
Biphasic Release
Pellets
Cellulosic Polymers
Experimental Design
topic Chronotherapy
Biphasic Release
Pellets
Cellulosic Polymers
Experimental Design
description Multiparticulate systems have biopharmaceutical advantages when compared to the monolithic systems, once they allow different patterns of drug release and can be used in different treatments. The aim of the present work was to develop a biphasic controlled release delivery system, using propranolol hydrochloride (PROP) that can be used for the treatment of circadian diseases. This system was obtained by the combination of cellulosic polymers hydroxypropyl methylcellulose (HPMC) and ethylcellulose (EC) in a 2² factorial experimental design, which allowed the optimization of the development stage. The pellets produced and used in biphasic formulations were evaluated for physical and chemical characteristics and presented acceptable results. The immediate fraction obtained showed the complete release in 30 min while the others kept the release of the drug for 24 h. This study showed that the combination of beads with different releasing characteristics allowed to obtain different release profiles, which can be modulated according to the pathological needs, especially with regard to circadian diseases that suffer alterations throughout the day.
publishDate 2018
dc.date.none.fl_str_mv 2018-12-20
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/159105
10.1590/s2175-97902018000417167
url https://www.revistas.usp.br/bjps/article/view/159105
identifier_str_mv 10.1590/s2175-97902018000417167
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/159105/154015
dc.rights.driver.fl_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2018 Brazilian Journal of Pharmaceutical Sciences
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 54 Núm. 4 (2018); e17167
Brazilian Journal of Pharmaceutical Sciences; v. 54 n. 4 (2018); e17167
Brazilian Journal of Pharmaceutical Sciences; Vol. 54 No. 4 (2018); e17167
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1800222913858633728